This article is more than 5 years old. Information may no longer be current.

HyperBranch licenses OcuSeal liquid ocular bandages to BD Medical

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

DURHAM, N.C. — HyperBranch Medical Technology has licensed its OcuSeal liquid ocular bandages to BD, HyperBranch announced in a press release.

Under the license, BD subsidiary BD Medical - Ophthalmic Systems will retain exclusive global rights to market OcuSeal ocular bandages for ophthalmic indications. BD Medical plans to begin international commercialization of the product immediately, the release said.

HyperBranch has been marketing and selling OcuSeal liquid ocular bandages through independent distributors since receiving a CE Mark in 2007.

"OcuSeal is a significant improvement for a variety of ophthalmic procedures, and BD is an excellent partner to offer this technology to a wider market," John Conn, president and chief executive officer of HyperBranch, said in the release. "The transaction with an industry leader like BD further validates our platform technology and in a very sensitive field of use."